Ansell (ASX:ANN) Shares Edge Higher Today: What Are Investors Watching After FY26 Results?

Sonal Goyal

06 November 2026 06:09 PM AEDT

Ansell (ASX:ANN) Shares Edge Higher Today: What Are Investors Watching After FY26 Results?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

Ansell (ASX:ANN) traded at A$45.66 during the 6 November 2026 session, up 0.31%.
FY26 adjusted EPS was US148.6 cents, in the upper half of guidance.
The final Dividend was US41.5 cents per share, a 50% payout ratio.

Ansell (ASX:ANN) shares were quoted at A$45.66 during the 6 November 2026 trading session, up 0.31%. The S&P/ASX 200 Health Care index (XHJ) eased 0.20% to 35,258.30 during the same session, while the S&P/ASX 200 was down 0.49% at 9,020.80. The session move is not linked to the 24 August 2026 full-year release. Ansell is a global safety solutions company, known for protective gloves and related products used in healthcare and industry.

Latest Developments

FY26 Full-Year Results (released 24 August 2026)

Ansell reported adjusted EPS of US148.6 cents, in the upper half of its guidance range. Sales growth accelerated in the second half with improved Volume trends, and EBIT Margin expanded on higher-value end markets. Sourcing actions and price increases offset US Tariff effects and cost Inflation linked to the Middle East. The board declared a final dividend of US41.5 cents, bringing the full-year payout to a 50% ratio.

About the Company

Ansell is an ASX-listed global safety solutions company. Its releases report in US dollars.

Business Overview

Ansell sells protective products, including gloves for healthcare and industrial use. Its FY26 release linked margin expansion to a mix shift toward higher-value end markets.

Sector Context

The S&P/ASX 200 Health Care Index (XHJ) eased 0.20% to 35,258.30 during the same session, while the S&P/ASX 200 was down 0.49% at 9,020.80. Protective equipment makers are affected by raw material costs, trade tariffs and Demand from healthcare and industrial customers.

Risks to Watch

The company noted US tariff effects and cost inflation linked to the Middle East during FY26. Currency movements affect a company reporting in US dollars with an ASX-listed price in Australian dollars.

Catalysts on Watch

Investors may follow the H1 FY27 result, trends in sales volumes and any update on tariff or input cost pressures.

Final Takeaways

Ansell (ASX:ANN) traded higher on 6 November 2026 in a session where the health care index eased. Its FY26 results, released on 24 August 2026, reported upper-half guidance delivery and a 50% payout ratio.

FAQs

Q: What was the ANN share price on 6 November 2026?

A: Ansell shares were quoted at A$45.66 during the trading session, up 0.31%.

Q: What was adjusted EPS?

A: US148.6 cents, in the upper half of guidance.

Q: What was the final dividend?

A: US41.5 cents per share, a 50% payout ratio.

Q: What affected margins?

A: Tariffs and cost inflation, offset partly by sourcing and price increases.

Q: Is the move linked to the results?

A: No. The results were released on 24 August 2026.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.